drugset / Trial / NCT02338323

Compare the Renal Protective Effects of Febuxostat and Benzbromarone

NCT02338323

Completed 160 enrolled Shanghai 10th People's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether febuxostat and benzbromarone could protect renal function, and which one could be better.

Timeline

Start
2015-01
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzbromarone Small molecule 50 mg Oral
Subject Febuxostat Small molecule 40 mg Oral